Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 11:48 AM
NCT ID:
NCT00412516
Eligibility Criteria:
Inclusion Criteria:
* Participant was enrolled in the JEV01 study previously conducted at RITM.
* Participant completed his/her vaccination schedule for the JEV01 study previously conducted at RITM.
* Participant's blood test results from JEV01 study indicate that he/she had seroconverted to measles vaccination.
* Participant's parents or legal guardian are/is willing to provide signed informed consent.
Exclusion Criteria:
* Participant was withdrawn from the JEV01 study for any reason.
* Receipt of immune globulin or other blood products within 6 months of study (JEV02) entry or receipt of injected or oral corticosteroids or other immune modulator therapy (except routine vaccines) within 4 weeks of study (JEV02) entry.
* Any condition that in the opinion of the investigator, would interfere with the evaluation of the study objectives.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Months
Maximum Age:
36 Months
Study:
NCT00412516
Study Brief:
Protocol Section:
NCT00412516